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e.2012.06Abstract Background: Pancreatic cancer is an uncommon tumor, but because the mortality rate
approaches 100%, this form of cancer has now become a common cause of cancer mortality.
Diabetes has been postulated to be both a risk factor and a consequence of pancreatic cancer,
but the degree of risk and associated clinical factors remain unclear.
Objectives: The objectives of this study were to investigate the incidence, clinical proﬁle, and the
frequency of associated factors of pancreatic cancer in Kuwait.
Methods: The study design was a retrospective hospital-based record study in which records of 251
pancreatic cancer patients registered, evaluated and treated at Kuwait cancer control center from
January 2004 through December 2010 were studied.
Results: The overall pancreatic cancer incidence was 0.9/100000 population. Pancreatic cancer was
more frequent in older, obese, smoker, diabetic Kuwaiti males with family history of pancreatic
cancer. Metastasis was diagnosed in 67.7% of patients at diagnosis of pancreatic cancer.
Conclusions: Pancreatic cancer in Kuwait is diagnosed in late stages. Screening for this disease was
indicated specially in diabetic patients. A comprehensive comparative study is required for determi-
nation of risk factors that could be associated with the disease.
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.0041. Introduction
Worldwide, pancreatic cancer ranks 13th in incidence but 8th
as a cause of cancer death.1 In different areas of the world,
pancreatic cancer is quite infrequent; the incidence is highest
in North America and Europe (11.8–12.5 cases per 100,000
people) and lowest in southern and eastern Asia and most of
Africa (<3.5 cases per 100,000 people). The incidence in India
is less than 2 cases per 100,000 persons per year.1and hosting by Elsevier B.V. All rights reserved.
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only 24%, and the overall 5-year survival is 5%.3 This is due
to the fact that pancreatic cancer is hard to catch early. It is
notoriously difﬁcult to diagnose in its early stages. At the time
of diagnosis, 52% of all patients have distant disease and 26%
have regional spread.4
Several personal and environmental factors have been asso-
ciated with pancreatic carcinogenesis. Cigarette smoking is the
most well-established environmental risk factor for pancreatic
cancer worldwide.5–8 Estimates indicate that 40% of pancre-
atic cancer cases are sporadic in nature. Another 30% are re-
lated to smoking, and 20% may be associated with dietary
factors. Only 5–10% are hereditary in nature.9 Diabetes melli-
tus may be associated with a 2-fold increase in the risk of
developing pancreatic cancer.10–12 Less than 5% of all pancre-
atic cancers are related to underlying chronic pancreatitis.13,14
Approximately 5–10% of patients with pancreatic cancer have
some genetic predisposition to developing the disease.15–17 In a
number of studies, obesity, especially central, has been associ-
ated with a higher incidence of pancreatic cancer.18 It was
found that being overweight or obese during early adulthood
was associated with a greater risk of pancreatic cancer and a
younger age of disease onset, while obesity at an older age
was associated with lower overall survival.19
In the absence of predisposing conditions, such as familial
pancreatic cancer and chronic pancreatitis, pancreatic cancer
is unusual in persons younger than 45 years. After an age of
50 years, the frequency of pancreatic cancer increases linearly.
The death rate from the disease has risen from 5 per 100,000
population in 1930 to more than 10 per 100,000 in 2003.3
To the best of our knowledge, few studies have been done
to investigate pancreatic cancer in Kuwait. Therefore, the
aim of our study was to assess the incidence, clinical proﬁle,
and the frequency of associated factors of pancreatic cancer
in Kuwait.Table 1 Incidence rate of pancreatic cancer in Kuwait 2000–
2010.
Year No. of new cases Population Rate/100,000
2000 29 2189668 1.3
2001 23 2243080 1.0
2002 22 2363325 0.9
2003 24 2484384 1.0
2004 16 2644777 0.6
2005 20 2866888 0.7
2006 33 3051845 1.1
2007 28 3328136 0.8
2008 29 3640427 0.8
2009 25 3442945 0.7
2010 27 3566437 0.8
Average 276 31821912 0.92. Methods
The study design was a hospital-based descriptive one relied
upon record study in which cases were retrospectively ascer-
tained. All the necessary approvals for carrying out the
research were obtained. The Ethics Committee of the Kuwaiti
Ministry of Health approved the research. A total of 276
patients with pancreatic cancer were registered during the
study period. Description of 251 patients was available
whereas full data for 25 cases were not available.
Cases were recruited from the population of patients diag-
nosed with pancreatic cancer who were registered, evaluated
and treated at Kuwait Cancer Control Center (KCCC) from
January 2000 through December 2010. The inclusion criteria
were patients with pathologically conﬁrmed diagnosis of pan-
creatic cancer. The exclusion criteria were presence of other
types of pancreatic disease, such as neuroendocrine tumor,
adenomas, cysts, or unknown primary tumors; concurrent
cancer at another organ site; and past history of cancer.
The necessary data were collected using a structured
questionnaire by trained persons who were able to extract
the information from the medical record or the data base of
KCCC registration center. The collected data included socio-
demographic and personal habits (age, gender, residence,
nationality, civil status); medical history (family history ofcancer or DM, presence of DM and its type and duration).
Also it included data related to pancreatic cancer (onset, initial
symptoms and signs, diagnosis and treatment).
Data were collected and coded then entered into an IBM
compatible computer, using the SPSS version 12 for Windows.
Qualitative variables were expressed as number and percentage
while quantitative variables were expressed as mean and stan-
dard deviation.
3. Results
Kuwait cancer registration center reported 276 new cases from
2000 to 2010, with 0.9/100000 population as an overall inci-
dence of pancreatic cancer. The highest incidence rate reported
in 2000 was 1.3/100000 population while, the lowest was re-
ported in the year 2004. No signiﬁcant trend was detected as
shown in Table 1.
Table 2 summarizes the demographic features of the pan-
creatic cancer patients. The overall ratio of men to women
was 1.5:1. The majority of patients were Kuwaiti (52.6%),
the Arab patients constituted 38.6% of cases and the non-Arab
constituted only 8.8%. Most of patients were from Hawally
and Farwaniya (26.3% and 24.7% respectively), and the rest
were from other governorates in Kuwait. The mean age of pa-
tients was 60.6 ± 7.7 years, the majority of cases were ﬁfty
years or older, whereas 31.1% were in the age group between
50 to less than 60 years and 59.4% were 60 years or more.
Table 3 illustrates the frequency of well-known risk factors
related to pancreatic cancer. About one ﬁfth of patients 19.9%
had positive family history of pancreatic cancer and 44.6%
had family history of diabetes mellitus. The mean BMI was
26.8 ± 4.8 and the majority of cases presented with overweight
and obesity whereas 36.3% of cases were overweight, 18.7%
were obese and 7.2% were very obese.
The proportion of pancreatic cancer patients with a history
of cigarette smoking was 38.2%. The majority of smokers gave
history of smoking at least one pack per day. Also, 61.4% of
smokers had history of smoking for 30 years or more, 25.5%
for 20–29 years and only 13.2% for less than 20 years with a
mean duration of smoking = 30.3 ± 10.2 years.
Patients with diabetes mellitus constituted 61.4%; and
52.6% of them were type 2. In 62.3% of patients, diabetes mel-
litus proceeded to pancreatic cancer and the reverse occurred
Table 2 Socio-demographic characteristics of pancreatic
cancer patients.
Variable No. %
Age groups
40- 24 9.6
50- 78 31.1
P60 149 59.4
Mean ± SD 60.7 ± 7.7
Gender
Male 150 59.8
Female 101 40.2
Nationality
Kuwaiti 132 52.6
Arab 97 38.6
Non Arab 22 8.8
Place of residence
Capital 38 15.1
Hawally 66 26.3
Mubarak 37 14.7
Jahra 32 12.7
Farwaniya 62 24.7
Ahmadi 16 6.4
Marital status
Single 12 4.8
Married 221 88.0
Divorced or widows 18 7.2
Total 251 100.0
Table 3 Frequency of associated factors among pancreatic
cancer patients.
Associated factors No %
Family history of pancreatic cancer
Yes 50 19.9
No 201 80.1
Family history of Diabetes mellitus
Yes 112 44.6
No 139 55.4
BMI
Normal 95 37.8
Overweight 91 36.3
Obese 47 18.7
Very obese 18 7.2
Mean ± SD 26.8 ± 4.8
Smoking history
Yes 96 38.2
No 155 61.8
Amount of smokinga
Non smokers 55 61.8
Half pack 8 3.2
One pack 36 14.3
1.5 pack 12 4.8
2 pack 31 12.4
More than 2 pack 9 3.6
Duration of smokinga
<20 13 13.5
20- 25 26.0
P30 58 60.4
Mean ± SD 30.3 ± 10.2
History of diabetes mellitus
No 97 38.6
Yes 154 61.4
Type of Diabetesb
Type 2 73 47.4
Type 1 81 52.6
Which is ﬁrstb
Diabetes mellitus ﬁrst 96 62.3
Cancer pancreas ﬁrst 58 37.7
Duration of diabetesb
<2 6 3.9
2- 7 4.5
4- 135 87.7
P6 6 3.9
Mean ± SD 5.2 ± 1.3
Duration of pancreatic cancer
<2 11 4.4
2- 67 26.7
4- 130 51.8
P6 43 17.1
Mean ± SD 4.6 ± 1.4
Total 251 100.0
a Non smokers were excluded.
b Non diabetic patients were excluded.
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litus among patients was 5.2 ± 1.3 years with more than 90%
having diabetes mellitus for four or more years. The mean
duration of pancreatic cancer was 4.6 ± 1.4 with 68.9% hav-
ing the disease for P4 years.
Table 4 shows the clinical and diagnostic characteristics of
pancreatic cancer patients. The majority of patients com-
plained from abdominal pain (91.2%), jaundice (87.6%), anor-
exia (39.4%) loss of weight (39.4%), and nausea and vomiting
(36.3%). Other complaints were less frequently encountered.
The same table reveals that 67.7% of patients were complain-
ing from metastasis either in liver (52.6%), lymph node (2.8%)
or on other sites (12.4%) at the time of diagnosis of pancreatic
cancer.
In slightly more than three quarters of patients (76.1%),
cancer was located in the head of the pancreas, 15.1% in the
tail and only 8.8% in the body. Only 45.8% of patients were
diagnosed clinically and 90% radiologically, where computed
tomography (CT) procedure was used in 75.3%. In addition,
more than 88.9% were diagnosed through biopsy (33.1%) or
tissue pathology (55.8%). The main lines of treatment given
to patients were surgery (47.8%), chemotherapy (61.0%) and
radiotherapy (18.3%)
4. Discussion
The current work is the ﬁrst epidemiological study of pancre-
atic cancer conducted in Kuwait. KCCC reported 276 new
cases from 2000 to 2010, with 0.9/1000000 population as an
overall incidence of pancreatic cancer. The incidence rates in
high-risk countries are about 5–7 times higher than incidence
rates in low-risk countries with accurate cancer registration,implying that environmental factors play an important
role.20,21 These wide variations may be due to the study design,
setting, population sample and technique used for diagnosis.
The low rate reported in Kuwait could be partially attributed
to the underestimation as many cases may not be registered as
those treated abroad and those who were admitted to the mil-
itary hospital. However these cases constituted a small propor-
tion to affect the rate signiﬁcantly.
Table 4 Clinical characteristics of pancreatic cancer patients.
Variables No. %
Initial symptoms
Abdominal pain 229 91.2
Jaundice 220 87.6
Nausea and vomiting 91 36.3
Anorexia 99 39.4
Weakness 32 12.7
Loss of weight 99 39.4
Constipation 27 10.8
Diarrhea 4 1.6
Backache 1 0.1
Fever 8 3.2
Enlarged abdomen 3 1.2
Metastasis 170 67.7
Liver 132 52.6
Lymph nodes 7 2.8
Others 31 12.4
Site of the cancer
Head 191 76.1
Body 22 8.8
Tail 38 15.1
Clinical diagnosis
No 136 54.2
Yes 115 45.8
Radiological diagnosis
No 25 10.0
X ray 8 3.2
Ultrasound 25 10.0
CT 189 75.3
MRI 4 1.6
Pathological diagnosis
Non 22 8.8
Biopsy 83 33.1
Tissue pathology 140 55.8
Other laboratory methods 6 2.4
Treatment
Surgery 120 47.8
Chemotherapy 153 61.0
Radiotherapy 46 18.3
Total 251 100.0
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and associated with pancreatic cancer as age, gender, family
history, duration of diabetes, BMI and smoking history. The
study demonstrated an increasing frequency of pancreatic can-
cer with advanced age. The mean age of patients was
60.6 ± 7.7 years, the majority of them were ﬁfty years or older,
where 31.1%were in age group between 50 to less than 60 years
and 59.4% were 60 years or more. This was in accordance with
the results reported in SEERCancer Statistics Review that pan-
creatic cancer is predominately a disease of older individuals
and almost all patients are older than 45.22 In consistent with
our results, Albert and Patrick23 reported that in the absence
of predisposing conditions, such as familial pancreatic cancer
and chronic pancreatitis, pancreatic cancer is unusual in per-
sons younger than 45 years but the frequency of pancreatic
cancer increases linearly after the age of ﬁfty.
The results of the present study revealed that males were
slightly more likely to develop pancreatic cancer than females.
This is due to, at least in part, increased tobacco use in males.
The American Cancer Society reported that the incidence ofpancreatic cancer in males was 12.1 cases and in females, the
rate was 9.1 cases per 100,000 persons per year.24 In the
USA, male rates were 40% higher than female rates while in
Japan the corresponding ﬁgure was 70%.22,25 These trends
probably represent the effect of changing smoking rates for
males than females.
The majority of patients in this study were Kuwaiti (52.6%)
and Arab patients (38.6%). The reasons for this are not clear.
However, Arnold et al. (26) found that excess pancreatic can-
cer in certain population group cannot be attributed to cur-
rently known risk factors, suggesting the possibility of the
underlying frequency of predisposing genetic mutations for
pancreatic cancer. Other explanation could be that non-Kuwa-
iti are mostly healthy individuals in the middle age who came
to Kuwait for work and might return to their countries before
reaching the age at which usually pancreatic cancer occurs.
A threefold greater risk for pancreatic cancer in subjects
with a positive family history of pancreatic cancer was re-
ported.27 Greer et al.15 reported that approximately 5–10%
of patients with pancreatic carcinoma have some genetic pre-
disposition for developing the disease.15 The current study
showed that about one ﬁfth (19.9%) of patients reported ﬁrst
degree positive family history of pancreatic cancer. This could
be due to an inherited syndrome, arranged marriage between
the same families, and/or due to a function of a shared envi-
ronmental exposure such as cigarette smoking.16,17,26–28
Studies evaluating the relationship between obesity and
pancreatic cancer have been inconsistent.29–31 In the present
study, the mean BMI was 26.8 ± 4.8 and the majority of cases
were either overweight and/or obese (36% and 19% respec-
tively). A recent meta-analysis reported that obese people
may have a 19 percent higher risk of pancreatic cancer than
those with a healthy BMI. The results, however, were not
conclusive.32
Our results showed that smoking for long duration was
encountered among our patients, where 38.2% of patients gave
history of smoking from one pack to more than two packs.
Moreover, 60.4% of smoking patients used to smoke for
30 years and more. Nearly all published reports showed that
smokers had about a 2-fold increased risk, compared to non-
smokers.7,8,10 The ﬁndings in these studies, performed in vari-
ous countries, were highly consistent.28,33
Numerous epidemiological studies have reported a positive
association between diabetes mellitus (DM) and the risk of pan-
creatic cancer.10,11,34 In the present study, patients with DM
constituted 61.4%, 52.6% of them were type 2 (T2DM). Sev-
eral studies revealed that pancreatic cancer is more common
in people with T2DM.10,11 The estimation of the overall risk
of pancreatic cancer among diabetics is consistent with the
up to 2-fold increase in risk reported by other investiga-
tors.11,35,36 The present study showed that DM proceeded to
pancreatic cancer in 62.5% and the reverse occurred among
37.7% of patients. The reason for this link is not known. Most
of the risk is found in people with T2DM as in our results. It is
often related to being overweight or obese. However, The Na-
tional Comprehensive Cancer Network (NCCN) guideline also
notes an association between sudden onset of T2DM in an
adult older than 50 years and a new diagnosis of pancreatic
cancer.13
Pancreatic cancer is commonly located at the head of
pancreas.35–37 In consistence, our study showed that slightly
more than three quarters of patients had cancer in the head
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et al., reported that pancreatic cancer was located in the head
of the pancreas in 71%, in the body in 21% and in the tail in
7%.38 This could be explained by the possibility of ingested to-
bacco products that reach the pancreas directly after reﬂux
into the pancreatic ductal system from the duodenum.38
In the present study, the majority of patients complained
from abdominal pain (91.2%), jaundice (87.6%), anorexia
(39.4%) loss of weight (39.4%), and nausea and vomiting
(36.3%). This is in agreement with several studies that reported
that pancreatic cancer does not manifest as early symptoms
and initial symptoms are often nonspeciﬁc, such as abdominal
discomfort, abdominal pain, weight loss, anorexia, and nau-
sea.36,37 Pain or jaundice are frequently presenting symptoms
with pain usually preceding jaundice.39,40
The vast majority of pancreatic cancers extend beyond the
pancreas when they are diagnosed.41,42 Our data showed that
liver and lymph nodes were the most common sites of metas-
tases among our patients. Early metastasis to regional and dis-
tant lymph nodes is also frequently observed.2
Occasionally, a pancreatic cancer is found incidentally dur-
ing an abdominal ultra sonography (US) examination.43 In the
current study, 45.8% were diagnosed clinically and 90% radio-
logically; the majority of them by computed tomography (CT)
(75.3%), in addition, more than 90% were diagnosed through
biopsy (33.1%), tissue pathology (55.8%) and other laboratory
methods (2.4%). Researchers reported that US and CT are the
imaging modalities that are most frequently used in the diag-
nosis of pancreatic cancer. Both modalities are useful in detect-
ing the primary tumor as well as extrapancreatic spread and
hepatic metastases.41,44
The study revealed that the main lines of treatment given to
patients were surgery (47.8%), chemotherapy (61.0%) and
radiotherapy (18.3%). From all treatment modalities em-
ployed in the management of pancreatic cancer, only surgery
has curative potential. Unfortunately, only a minority of pa-
tients with pancreatic cancer will be suitable candidates for
pancreatic resection with curative intent, mostly due to the fact
that the disease does not produce distinct symptomatology in
its early stages. Subsequently, the vast majority of patients
have locally advanced or disseminated disease at the time of
diagnosis.2,45–47
We acknowledged certain limitations of our study. Firstly,
the calculated incidence could be lower than the actual ﬁgure
due to missing of cases treated in the military hospital and/
or private sector. Secondly, as we relied upon record study,
the data obtained might be, to certain extent, affected by the
quality of recording. Thirdly, as in any descriptive study, con-
clusion regarding associated variables as risk factors could not
be reached. Nevertheless, the results are consistent with those
coming from comparative studies.
5. Conclusion
The incidence of pancreatic cancer in Kuwait is relatively low.
Pancreatic cancer in Kuwait is diagnosed in late stages. Screen-
ing for this disease should be performed specially in patients
with T2DM and family history of cancer. Future studies on
pancreatic cancer should be done and directed strongly to
the assessment of related risk factors hence, concentrating on
genetic, environmental and quality of life factors.Acknowledgement
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